Edward Sawicki Jr's guest appearances

Edward Sawicki Jr

Finding Genius Podcast

FutureTech Podcast

Laura Potterat

Marc Guell

Paul Turner

Jan Vijg

Eleftherios Mylonakis

Cory Kidd

Charles C.J

Helius Medical Technologies

Patrick McKeown

Michael G. Surette

Katelyn Parsons

John Tucker

Jake Kushner

Erik Gunther

Kim Kush

OwlTail

In this podcast, Edward Sawicki Jr., MBA, the CEO of Think20 Labs, LLC (think20labs.com), talks about cannabis research and what it holds for the future of medicine. Sawicki is an outspoken cannabis advocate who is bringing scientific research and education together to demonstrate the enormous benefits of cannabis to the medical world. Sawicki has extensive experience in biotech as he has been heavily involved with lab design for DNA-sequencing labs, molecular biology labs, and more. Sawicki discusses his background, molecular development, and the future of cannabis. As he states, Think20 Labs is involved in much more than basic compliance testing; their work includes sequencing of DNA, epigenetics, and voluminous research, as well as project design. Sawicki expounds upon the many ways that cannabis can push medicine forward and how full legalization is critically important in order to fully expand research and ensure safety of product. Sawicki discusses the many local growers they work with, and the data that they are continually collecting in regard to plants and soil conditions. Currently, safety for consumers, as well as compliance, are two of their most important issues. Sawicki talks about black market products, and their dangers, and how expanded legalization, with standards, will improve safety for all involved. Additionally, Sawicki discusses the important research into epigenomic and RNA profiles that can help them find correlations, and inform researchers about what they need to learn, and how to approach experimentation, testing, and learning.

In this podcast, Edward Sawicki Jr., MBA, the CEO of Think20 Labs, LLC (<a href="http://think20labs.com" rel="nofollow" target="_blank">think20labs.com</a>), talks about cannabis research and what it holds for the future of medicine. Sawicki is an outspoken cannabis advocate who is bringing scientific research and education together to demonstrate the enormous benefits of cannabis to the medical world. Sawicki has extensive experience in biotech as he has been heavily involved with lab design for DNA-sequencing labs, molecular biology labs, and more. Sawicki discusses his background, molecular development, and the future of cannabis. As he states, Think20 Labs is involved in much more than basic compliance testing; their work includes sequencing of DNA, epigenetics, and voluminous research, as well as project design. Sawicki expounds upon the many ways that cannabis can push medicine forward and how full legalization is critically important in order to fully expand research and ensure safety of product. Sawicki discusses the many local growers they work with, and the data that they are continually collecting in regard to plants and soil conditions. Currently, safety for consumers, as well as compliance, are two of their most important issues. Sawicki talks about black market products, and their dangers, and how expanded legalization, with standards, will improve safety for all involved. Additionally, Sawicki discusses the important research into epigenomic and RNA profiles that can help them find correlations, and inform researchers about what they need to learn, and how to approach experimentation, testing, and learning.

Connecting to Cannabis – Edward Sawicki Jr., CEO of Think20 Labs –Cannabis Research and Testing for Expanded Medical Uses

Edward Sawicki Jr., MBA, Chief Executive Officer at Think20 Labs, LLC (think20labs.com), discusses his vision for the future of cannabis. Sawicki’s mission is to help expand personalized medicine and ensure safety for consumers in the cannabis market. He is a cannabis advocate and is heavily involved in the education of consumers about the many benefits of cannabis. Sawicki has a rich background in the biotech space assisting with lab design for DNA-sequencing and molecular biology labs. Sawicki talks about the premise of Think20 Labs and his background. He explains that Think20 Labs is much more than a testing company, that his company wants to encompass everything they know about molecular development and beyond. Think20 Labs is heavily involved in not only compliance testing, but the sequencing of DNA, epigenetic work, and so much more in research, and the design of projects as well. Sawicki explains that Think20 Labs seeks to get to the core of what cannabis can truly do to move medicine forward and help individuals who suffer from a wide variety of maladies. As he explains, full legalization is needed in order to expand the research. The cannabis research expert talks about the individualized work they do with local growers, and the massive data that they are collecting about plants and soil conditions, etc. As he states, the most important issue right now is ensuring safety for consumers, and compliance. He discusses the dangers of products that come from the black market, and how full legalization with standards will help to improve safety. Wrapping up, he talks about how research into epigenomic and RNA profiles will help them to figure out where the important correlations lie, in regard to understanding what they need to learn, and how to approach that in an ordered fashion. Sawicki states that by starting with genetic profiles of patients and of plants, their research can begin to find important correlations that will guide further research, ongoing.

Edward Sawicki Jr., MBA, Chief Executive Officer at Think20 Labs, LLC (<a href="http://think20labs.com" rel="nofollow" target="_blank">think20labs.com</a>), discusses his vision for the future of cannabis. Sawicki’s mission is to help expand personalized medicine and ensure safety for consumers in the cannabis market. He is a cannabis advocate and is heavily involved in the education of consumers about the many benefits of cannabis. Sawicki has a rich background in the biotech space assisting with lab design for DNA-sequencing and molecular biology labs. Sawicki talks about the premise of Think20 Labs and his background. He explains that Think20 Labs is much more than a testing company, that his company wants to encompass everything they know about molecular development and beyond. Think20 Labs is heavily involved in not only compliance testing, but the sequencing of DNA, epigenetic work, and so much more in research, and the design of projects as well. Sawicki explains that Think20 Labs seeks to get to the core of what cannabis can truly do to move medicine forward and help individuals who suffer from a wide variety of maladies. As he explains, full legalization is needed in order to expand the research. The cannabis research expert talks about the individualized work they do with local growers, and the massive data that they are collecting about plants and soil conditions, etc. As he states, the most important issue right now is ensuring safety for consumers, and compliance. He discusses the dangers of products that come from the black market, and how full legalization with standards will help to improve safety. Wrapping up, he talks about how research into epigenomic and RNA profiles will help them to figure out where the important correlations lie, in regard to understanding what they need to learn, and how to approach that in an ordered fashion. Sawicki states that by starting with genetic profiles of patients and of plants, their research can begin to find important correlations that will guide further research, ongoing.

Cannabis Concepts – Edward Sawicki Jr., MBA, Chief Executive Officer at Think20 Labs, LLC – Unlocking the Many and Various Medical Uses for Cannabis